Sinopharm Group Co. Ltd.
SHTDY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $62 | $58 | $54 | $43 |
| - Cash | $54 | $64 | $55 | $44 |
| + Debt | $76 | $74 | $70 | $68 |
| Enterprise Value | $84 | $68 | $69 | $68 |
| Revenue | $585 | $597 | $552 | $521 |
| % Growth | -2% | 8% | 6% | – |
| Gross Profit | $44 | $49 | $47 | $44 |
| % Margin | 7.6% | 8.1% | 8.6% | 8.5% |
| EBITDA | $20 | $27 | $26 | $25 |
| % Margin | 3.5% | 4.5% | 4.8% | 4.7% |
| Net Income | $7 | $9 | $9 | $8 |
| % Margin | 1.2% | 1.5% | 1.5% | 1.5% |
| EPS Diluted | 11.3 | 14.5 | 13.65 | 12.45 |
| % Growth | -22.1% | 6.2% | 9.6% | – |
| Operating Cash Flow | $12 | $17 | $21 | $9 |
| Capital Expenditures | -$2 | -$2 | -$2 | -$2 |
| Free Cash Flow | $10 | $15 | $19 | $7 |